Samumed is a pharmaceutical platform company that has made groundbreaking advances in the biology of tissue regeneration through the discovery of novel targets and processes in the Wnt pathway. Samumed is conducting early to advanced-stage clinical trials with several disease-modifying drug candidates. These trials cover a range of disease including osteoarthritis, oncology, Alzheimer’s disease, degenerative disc disease, idiopathic pulmonary fibrosis, tendinopathy and androgenetic alopecia.
Exhibiting Company is Associated with these Practice Area(s): Foot and Ankle, Hip and Knee (Adult Reconstructive), Spine, Shoulder and Elbow, Sports Medicine, Basic Science, Pain Management, Total Joint
Learning Experience(s) available in this booth are: Wnt signaling pathway education, new investigational osteoarthritis drug candidate MOA, osteoarthritis disease awareness, clinical program education